Evidence map›Paper›PMID 20011137›Full record

ReviewInternational journal of biological sciences2009

Physiological and oncogenic Aurora-A pathway.

Toshiaki Saeki, Mutsuko Ouchi, Toru Ouchi

Abstract readReview
In one paragraph

Review in International journal of biological sciences, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. [The function of Aurora A and its role in the development of liver cancer].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017
    Article
  7. Article
  8. Article
  9. Translational biology of osteosarcoma.Nature reviews. Cancer · 2014
    Review
  10. Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Current and future trials of targeted therapies in cutaneous melanoma.Advances in experimental medicine and biology · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. Cyclin B1 expression regulated by cytoplasmic polyadenylation element binding protein in astrocytes.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Toshiaki SaekiDepartment of Breast Oncology, Saitama Medical School, Japan.
Mutsuko Ouchi
Toru Ouchi

Funding

Model of Tumor Suppression by BRCA1R01CA090631 · NCI · NORTHSHORE UNIVERSITY HEALTHSYSTEM · PI OUCHI, TORU · 2002 to 2011
$2.7M
REGULATION OF P53 FUNCTION BY BRCA1 TUMOR SUPPRESSORR01CA079892 · NCI · NORTHSHORE UNIVERSITY HEALTHSYSTEM · PI OUCHI, TORU · 1999 to 2008
$1.8M
DNA Damage Checkpoint and CancerU01CA090631 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI OUCHI, TORU · 2011 to 2012
$626k
NCI NIH HHS CA79892NCI NIH HHS CA90631NCI NIH HHS R01 CA079892NCI NIH HHS R01 CA090631NCI NIH HHS U01 CA090631
6 · The paper itself

Abstract

Aurora family of protein kinases have emerged as crucial factors of, not only mitosis and cytokinesis, but also human carcinogenesis. Among these family members is Aurora-A that is frequently overexpressed in varieties of human cancer. Both in vitro and in vivo studies demonstrated that Aurora-A induces tumorigenesis through genome instability. These studies have further shown that cell signaling cross-talk between Aurora-A and other cellular proteins are essential for fully-transformed phenotypes. This review summarizes recent progress of Aurora-A-associated carcinogenesis.

Indexed as

Cell Transformation, NeoplasticAnimalsAurora KinasesBRCA1 ProteinCell Cycle ProteinsHumansIntracellular Signaling Peptides and ProteinsNeoplasmsPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsSignal TransductionTOR Serine-Threonine KinasesAurora KinasesBRCA1 ProteinCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsMTOR protein, humanPolo-Like Kinase 1Protein Serine-Threonine KinasesProto-Oncogene ProteinsTOR Serine-Threonine KinasesAurora-ACell CycleCheckpointGenome InstabilitymTORPhosphorylationPlk1

Identifiers

PMID20011137
PMCPMC2793309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.